UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 73

Sortiert nach

Breast cancer mortality in Norway after the introduction of mammography screening

International journal of cancer, 2013-01, Vol.132 (1), p.208-214

2013

Link zum Volltext

Verfügbarkeit prüfen

The potential for prevention of colorectal cancer in the UK

European journal of cancer prevention, 2009-06, Vol.18 (3), p.179

2009

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study

BMJ (Online), 2005-01, Vol.330 (7485), p.220

International edition, 2005

Link zum Volltext

Verfügbarkeit prüfen

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database

International Journal of Obesity, 2021-06, Vol.45 (6), p.1249-1258

2021

Link zum Volltext

Verfügbarkeit prüfen

Investigating the potential non‐authorized use of two different formulations of liraglutide in Europe: A real‐world drug utilization study

Diabetes, obesity & metabolism, 2023-04, Vol.25 (4), p.985-991

2023

Link zum Volltext

Verfügbarkeit prüfen

Obesity, cardiovascular risk and healthcare resource utilization in the UK

European journal of preventive cardiology, 2021-09, Vol.28 (11), p.1235

2021

Link zum Volltext

Verfügbarkeit prüfen

Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study

Journal of managed care & specialty pharmacy, 2021-02, Vol.27 (2), p.210

2021

Link zum Volltext

Verfügbarkeit prüfen

Overdiagnosis in screening mammography in Denmark: population based cohort study

BMJ (Online), 2013-02, Vol.346 (7901), p.f1064

International edition, 2013

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark

Breast cancer research and treatment, 2020-12, Vol.184 (3), p.891-899

2020

Link zum Volltext

Verfügbarkeit prüfen

Screening opportunity bias in case-control studies of cancer screening

Journal of applied statistics, 2008-05, Vol.35 (5), p.537-546

2008

Link zum Volltext

Verfügbarkeit prüfen

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Advances in therapy, 2022-08, Vol.39 (8), p.3735-3748

2022

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes

Acta oncologica, 2006, Vol.45 (5), p.528-535

2006

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Advances in therapy, 2023, Vol.40 (1), p.389-390

2023

Link zum Volltext

Verfügbarkeit prüfen

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

Journal of medical screening, 2010-01, Vol.17 (1), p.25-30

2010

Link zum Volltext

Verfügbarkeit prüfen

A model for determining the effect of mammography service screening

Acta oncologica, 2005-03, Vol.44 (2), p.120-128

2005

Link zum Volltext

Verfügbarkeit prüfen

Mammography activity in Norway 1983 to 2008

Acta oncologica, 2011-10, Vol.50 (7), p.1062-1067

2011

Link zum Volltext

Verfügbarkeit prüfen

Socio‐demographic determinants of participation in mammography screening

International journal of cancer, 2008-01, Vol.122 (2), p.418-423

2008

Link zum Volltext

Verfügbarkeit prüfen

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

Journal of the Endocrine Society, 2023-05, Vol.7 (6), p.bvad054-bvad054

2023

Link zum Volltext

Verfügbarkeit prüfen

Obesity, cardiovascular risk and healthcare resource utilization in the UK

European journal of preventive cardiology, 2020-05, p.2047487320925639

2020

Link zum Volltext

Verfügbarkeit prüfen

Author's reply: Breast cancer mortality in Norway after the introduction of mammography screening

International journal of cancer, 2013-04, Vol.132 (7), p.1727-1727

2013

Link zum Volltext

Verfügbarkeit prüfen

Is there an association between liraglutide use and female breast cancer in a real-world setting?

Diabetes, metabolic syndrome and obesity, 2018-01, Vol.11, p.791-806

2018

Link zum Volltext

Verfügbarkeit prüfen

Estimating the Benefits of Mammography Screening: The Impact of Study Design

Epidemiology (Cambridge, Mass.), 2007-07, Vol.18 (4), p.487-492

2007

Link zum Volltext

Verfügbarkeit prüfen

Predicting the risk of a false-positive test for women following a mammography screening programme

Journal of medical screening, 2007-06, Vol.14 (2), p.94-97

2007

Link zum Volltext

Verfügbarkeit prüfen

Overdiagnosis, Sojourn Time, and Sensitivity in the Copenhagen Mammography Screening Program

The breast journal, 2006-07, Vol.12 (4), p.338-342

2006

Link zum Volltext

Verfügbarkeit prüfen

Breast cancer incidence after the introduction of mammography screening : What should be expected?

Cancer, 2006-05, Vol.106 (9), p.1883-1890

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(60)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(45)
Humans
(42)
Female
(34)
Middle Aged
(28)
Aged
(23)
Mammography
(19)
Oncology
(16)
Denmark - Epidemiology
(13)
Adult
(12)
Breast Neoplasms - Diagnostic Imaging
(12)
Breast Cancer
(11)
Biological And Medical Sciences
(10)
Male
(10)
Breast Neoplasms - Mortality
(9)
Medical Sciences
(9)
Mortality
(9)
Risk Factors
(9)
Screening
(9)
Tumors
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Breast cancer mortality in Norway after the introduction of mammography screening

The potential for prevention of colorectal cancer in the UK

Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study

Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database

Investigating the potential non‐authorized use of two different formulations of liraglutide in Europe: A real‐world drug utilization study

Obesity, cardiovascular risk and healthcare resource utilization in the UK

Complication-specific direct medical costs by body mass index for 13 obesity-related complications: a retrospective database study

Overdiagnosis in screening mammography in Denmark: population based cohort study

Breast cancer mortality and overdiagnosis after implementation of population-based screening in Denmark

Screening opportunity bias in case-control studies of cancer screening

Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes

Correction to: Initiating or Switching to Insulin Degludec/Insulin Aspart in Adults with Type 2 Diabetes: A Real-World, Prospective, Non-interventional Study Across Six Countries

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England

A model for determining the effect of mammography service screening

Mammography activity in Norway 1983 to 2008

Socio‐demographic determinants of participation in mammography screening

Long-term Effectiveness and Safety of GH Replacement Therapy in Adults ≥60 Years: Data From NordiNet® IOS and ANSWER

Obesity, cardiovascular risk and healthcare resource utilization in the UK

Author's reply: Breast cancer mortality in Norway after the introduction of mammography screening

Is there an association between liraglutide use and female breast cancer in a real-world setting?

Estimating the Benefits of Mammography Screening: The Impact of Study Design

Predicting the risk of a false-positive test for women following a mammography screening programme

Overdiagnosis, Sojourn Time, and Sensitivity in the Copenhagen Mammography Screening Program

Breast cancer incidence after the introduction of mammography screening : What should be expected?

Suchergebnisse filtern